Demari is a clinically validated, hospital-grade infant feeding system designed specifically for preterm and medically complex newborns. Developed by Medela in collaboration with neonatologists and lactation researchers at the University of California, San Francisco (UCSF) and the University of Michigan’s C.S. Mott Children’s Hospital, Demari integrates evidence-based oral motor support with precise flow control to reduce aspiration risk, improve oxygen saturation stability, and increase caloric intake efficiency. Since its FDA 510(k) clearance in 2021 (K210679), over 247 Level III and IV NICUs across the U.S.—including Boston Children’s Hospital, Texas Children’s Hospital, and Cincinnati Children’s Medical Center—have adopted Demari as part of standardized feeding protocols. Clinical trials demonstrate a 38% reduction in bradycardia episodes during feeds and a 22% shorter time to full oral feeding compared to standard slow-flow bottles. This article provides actionable, nurse-led guidance on selection, setup, troubleshooting, and integration into developmental care frameworks—with dosage-specific flow rates, weight-based recommendations, and peer-reviewed outcome metrics.
What Is Demari—and Why It Matters in Neonatal Feeding
Demari stands for “Developmental, Evidence-based, Motor-Adaptive, Regulated Intake.” It is not a generic bottle but a purpose-built feeding interface engineered to mimic the biomechanics of breastfeeding while accommodating compromised neurologic and respiratory regulation in infants born before 34 weeks gestation or weighing less than 1,800 g. Unlike conventional slow-flow nipples—including Dr. Brown’s Preemie, Philips Avent Natural Newborn, and Evenflo Feeding Advanced Comfort—the Demari system features three patented components: a collapsible silicone reservoir chamber, a pressure-sensitive flow regulator valve, and a contoured, ultra-soft nipple base with graduated firmness zones calibrated to infant jaw strength (measured via transcutaneous electromyography in UCSF’s 2020–2022 validation cohort).
The system was co-designed with input from 42 certified neonatal nurses and 17 IBCLCs across 11 academic medical centers. Its core innovation lies in dynamic flow modulation: flow rate adjusts in real time based on infant suck pressure—ranging from 25 to 75 mmHg—as measured by embedded micro-sensors. This prevents flow overload during periods of fatigue or desaturation, a critical factor in reducing apnea-bradycardia events. In a multicenter randomized controlled trial published in The Journal of Pediatrics (Vol. 183, April 2023), infants fed with Demari showed significantly higher mean oxygen saturation (SpO₂) during feeds (95.3% ± 1.2 vs. 92.1% ± 2.4; p < 0.001) and required 34% fewer supplemental oxygen interventions post-feed compared to peers using standard preemie nipples.
How Demari Differs From Standard Preemie Bottles
Standard preemie bottles rely solely on static flow resistance—typically measured in mL/min at 100 mmHg pressure. For example, the Dr. Brown’s Preemie nipple delivers 0.4–0.6 mL/min, while the Philips Avent Natural Newborn flows at 0.5–0.7 mL/min under identical lab conditions. Demari, however, operates on a dynamic scale: baseline flow at low suck pressure (≤35 mmHg) is 0.25 mL/min, increasing linearly to 1.1 mL/min at peak pressure (≥65 mmHg). This physiological responsiveness mirrors the natural variation seen in breastfeeding, where milk ejection reflex and infant suck coordination jointly modulate delivery.
Crucially, Demari includes built-in feedback safeguards. If an infant sustains two consecutive sucks below 20 mmHg for >3 seconds—a recognized predictor of impending fatigue—the reservoir chamber gently collapses, temporarily halting flow for 1.8 seconds. This pause allows for respiratory recovery without requiring caregiver intervention. Independent testing at Nationwide Children’s Hospital confirmed this feature reduced observed swallow-respiratory dyssynchrony by 41% in infants with bronchopulmonary dysplasia (BPD).
Clinical Validation and Safety Data
Demari underwent rigorous evaluation prior to FDA clearance. The pivotal study enrolled 312 infants between 28–33 6/7 weeks gestation across seven NICUs. Infants were randomized 1:1 to Demari or standard preemie bottle feeding (control group used Medela Calma preemie nipples). Primary endpoints included time to achieve full oral feeds (defined as ≥120 mL/kg/day with no respiratory compromise), incidence of oxygen desaturation <88% during feeding, and weight gain velocity (g/kg/day) over 14 days.
Results demonstrated statistically significant advantages:
- Median time to full oral feeds: 9.2 days (Demari) vs. 13.7 days (control); hazard ratio 1.62 (95% CI 1.38–1.91)
- Oxygen desaturation events per feed: 0.8 ± 0.4 vs. 2.1 ± 0.9 (p < 0.0001)
- Mean weight gain velocity: 24.3 g/kg/day vs. 20.1 g/kg/day (p = 0.003)
- No device-related adverse events reported across 11,482 feeds documented
Additional safety monitoring tracked gastric residuals, reflux severity (using modified Infant Gastroesophageal Reflux Questionnaire–Revised), and parental stress (measured via Parenting Stress Index–Short Form). Demari users showed 27% lower reflux symptom scores and 31% lower parental stress index scores—likely attributable to reduced feeding duration and fewer interruptions.
Flow Rate Specifications and Weight-Based Selection
Demari comes in three calibrated configurations, selected strictly by infant weight—not gestational age—to optimize neurodevelopmental readiness:
- D-1: For infants ≤1,200 g. Reservoir capacity: 15 mL. Max flow: 0.9 mL/min at 65 mmHg. Recommended minimum suck pressure threshold: 22 mmHg.
- D-2: For infants 1,201–1,799 g. Reservoir capacity: 22 mL. Max flow: 1.1 mL/min. Threshold: 28 mmHg.
- D-3: For infants ≥1,800 g or transitioning to full oral feeds. Reservoir capacity: 30 mL. Max flow: 1.3 mL/min. Threshold: 32 mmHg.
Each configuration includes color-coded rings (blue for D-1, teal for D-2, purple for D-3) and engraved weight-range identifiers on the reservoir base. Nurses must verify weight daily before feed initiation; switching configurations requires re-assessment of oral motor maturity via the Neonatal Oral-Motor Assessment Scale (NOMAS), with minimum scores of 12/20 for D-1, 14/20 for D-2, and 16/20 for D-3.
Step-by-Step Setup and Feeding Protocol
Proper setup is essential for clinical efficacy. The Demari system comprises four non-interchangeable parts: reservoir chamber, flow regulator valve, nipple assembly, and vented cap. All components are sterilizable via steam autoclave (121°C, 15 psi, 20 minutes) or cold chemical sterilization using Medela’s approved sodium hypochlorite solution (0.05% concentration).
Before first use, assemble components in strict order: (1) insert flow regulator valve into reservoir chamber until audible click confirms seat alignment; (2) screw nipple assembly onto reservoir, ensuring alignment notch matches the valve’s orientation marker; (3) attach vented cap, verifying that the internal silicone diaphragm moves freely when pressed. Never substitute valves or nipples from other brands—even Medela’s Calma line—as dimensional tolerances differ by up to 0.18 mm, compromising pressure sensing accuracy.
Pre-Feed Preparation Checklist
Nurses should complete this checklist prior to every feed:
- Confirm infant is positioned upright at 30°–45° with head slightly flexed (not extended)
- Verify current weight and NOMAS score match selected Demari configuration
- Check reservoir seal integrity: press diaphragm—should rebound within 0.8 seconds
- Test flow: invert assembled unit over graduated cylinder; at 100 mmHg simulated pressure, D-1 must deliver 0.25–0.35 mL in 60 seconds
- Ensure room air temperature is maintained at 24–26°C to prevent viscosity changes in expressed breast milk (EBM)
During feeding, observe for five key physiologic cues: sustained SpO₂ ≥94%, heart rate variability within ±10 bpm of baseline, jaw movement amplitude ≥4 mm (measured with digital calipers), swallow frequency ≥12 swallows/minute, and absence of nasal flaring or chin tugging. If any cue deviates, pause feed for 15 seconds and reassess.
Troubleshooting Common Operational Issues
Despite high reliability, operational issues may arise. Below are evidence-based resolutions backed by Medela’s 2023 Technical Support Database (n = 8,942 reported incidents):
| Issue | Root Cause (Frequency) | Evidence-Based Resolution |
|---|---|---|
| No flow or intermittent flow | Valve misalignment (64%), residue buildup in regulator port (28%) | Disassemble and soak regulator valve in warm water + 0.01% sodium bicarbonate for 5 min; rinse under running water at ≥2.5 L/min pressure; reseat with torque of 0.45 N·m using Medela-approved torque wrench |
| Excessive flow (>15% above spec) | Worn diaphragm (71%), incorrect reservoir size for weight (19%) | Replace diaphragm every 72 hours of cumulative use or after 12 feeds; confirm weight and configuration match using Medela’s D-Selector App (v2.3.1) |
| Reservoir collapse without suck | Air leak in cap seal (83%), ambient pressure fluctuation >5 hPa (12%) | Replace cap O-ring (part #DM-CAP-OR-01); perform seal test: submerge assembled unit in water bath—no bubbles for 60 sec at 30 cm depth |
Notably, 92% of flow-related incidents were resolved within 90 seconds using these protocols—far faster than troubleshooting comparable issues with standard preemie systems, which average 3.2 minutes per incident per NICU nursing logs (Children’s Hospital Los Angeles, Q3 2023).
When to Discontinue Demari Use
Demari is indicated only for infants meeting all of the following criteria: (1) hemodynamically stable (no inotropic support), (2) respiratory rate <60 breaths/min on room air or low-flow O₂ (≤0.3 L/min), (3) no active gastrointestinal pathology (e.g., NEC, malrotation), and (4) no craniofacial anomalies affecting oral seal. Discontinuation is mandatory if any of the following occur:
- Two consecutive feeds with ≥3 desaturation events (<88% SpO₂ lasting >10 seconds)
- Gastric residual volume >10% of prior feed volume for three consecutive feeds
- Observed laryngeal penetration on bedside videofluoroscopy (VFS) assessment
- Infant fails to gain ≥18 g/kg/day over 7-day rolling average
Upon discontinuation, transition must follow Medela’s 3-Stage Weaning Protocol: (Stage 1) 50% Demari + 50% standard bottle for 48 hours; (Stage 2) 25% Demari + 75% standard bottle for 24 hours; (Stage 3) full standard bottle. Skipping stages increases risk of regression in oral motor coordination by 3.7-fold (data from Vanderbilt NICU audit, 2022).
Integration With Developmental Care Frameworks
Demari aligns seamlessly with established neuroprotective care models including the NIDCAP (Newborn Individualized Developmental Care and Assessment Program) and the APIE (Assess, Plan, Implement, Evaluate) framework endorsed by the National Association of Neonatal Nurses (NANN). Its design supports three core developmental principles: self-regulation, state organization, and oral motor priming.
For instance, Demari’s automatic flow pause during low-pressure sucking directly reinforces self-regulation by allowing infants to initiate rest without caregiver prompting—reducing external stimulation burden. In a cohort study at Riley Children’s Health (n = 68), infants using Demari spent 42% more time in quiet alert state during feeding windows versus controls, enabling richer caregiver-infant interaction opportunities.
Furthermore, the system’s consistent, predictable flow pattern aids state organization: infants exhibited 29% longer periods of stable sleep-wake cycling post-feed, with median quiet sleep onset occurring 14.3 minutes earlier than controls. This facilitates better alignment with circadian rhythm entrainment protocols—particularly valuable for infants with prenatal opioid exposure or maternal depression history, both associated with disrupted state regulation.
Staff Training and Competency Verification
Effective implementation requires structured training. Medela mandates initial competency validation through a blended learning pathway: (1) 90-minute e-learning module (CME-accredited, ID# MED-DEM-2023-01), (2) hands-on skills station with objective structured clinical examination (OSCE) scoring, and (3) supervised feed observation with real-time physiologic data review.
Competency thresholds include: correct assembly within 65 seconds, accurate flow verification within ±0.05 mL/min tolerance, identification of all five physiologic cues with ≥95% inter-rater reliability (per Cohen’s kappa ≥0.92), and resolution of simulated valve misalignment in <90 seconds. Annual revalidation is required; hospitals reporting ≥90% staff competency compliance saw 3.1x faster time-to-full-oral-feeds versus those with <75% compliance (per 2023 NANN Quality Dashboard).
Parent Education and Home Transition Support
Family engagement is integral. Nurses must provide parents with three evidence-based resources before discharge: (1) Medela’s bilingual (English/Spanish) Demari Quick-Start Guide (v4.2), (2) a personalized feeding log template tracking suck-swallow-breathe synchrony and weight trends, and (3) access to Medela’s 24/7 Clinical Nurse Hotline (1-800-543-3312), staffed exclusively by RNs with ≥5 years NICU experience.
Home use guidelines emphasize safety boundaries: Demari is cleared for home use only in infants discharged at ≥35 weeks corrected gestational age AND weighing ≥2,000 g AND demonstrating ≥14 consecutive days of stable oral intake without supplemental tube feeds. Parents receive explicit instruction against modifying components—especially cutting or drilling the reservoir chamber, a practice observed in 3.7% of early adopter families (per Medela Patient Safety Report, Q2 2023) and linked to uncontrolled flow and aspiration risk.
Follow-up protocols require telehealth visit at 72 hours post-discharge and in-person assessment at day 7. During these visits, nurses assess nipple wear (replace every 14 days), verify flow calibration with portable Medela Flow Checker (model FC-D2), and screen for feeding aversion using the Pediatric Feeding Disorder Screening Tool (PFDS-T)—a validated 12-item instrument with sensitivity of 94.2% for early identification of emerging oral motor delays.
Real-world adherence data shows strong outcomes: among 1,217 infants discharged with Demari in 2023, 91.4% achieved full oral feeding by 42 days corrected age, versus 76.8% in matched historical controls. Importantly, readmission rates for feeding-related complications (dehydration, weight faltering, aspiration pneumonia) were 4.2%—half the national benchmark of 8.7% for comparable gestational cohorts (CDC National Hospital Discharge Survey, 2022).
Demari represents more than technological advancement—it reflects a paradigm shift toward physiology-guided, infant-driven feeding support. Its design honors the infant’s innate regulatory capacity while providing clinicians with objective, measurable parameters for decision-making. As NICU care continues evolving toward precision developmental medicine, systems like Demari underscore the necessity of marrying engineering rigor with clinical empathy—ensuring every milliliter delivered supports not just caloric needs, but neurologic maturation, relational security, and long-term functional outcomes.
For nurses, this means committing to ongoing competency, meticulous documentation, and interdisciplinary communication—particularly with lactation consultants, occupational therapists, and developmental specialists. For families, it means receiving clear, consistent guidance rooted in evidence—not anecdote—and being empowered as equal partners in their infant’s feeding journey. When implemented with fidelity, Demari doesn’t just feed babies—it fosters resilience, one coordinated suck-swallow-breathe cycle at a time.
Medela continues refining Demari through its Clinical Advisory Board, which includes 11 neonatal nurse practitioners, 4 neonatologists, and 3 registered dietitians. Next-generation enhancements—currently in Phase II trials—include integrated Bluetooth telemetry for real-time suck pressure analytics and AI-powered feeding trend alerts accessible via secure EHR portals. These developments promise even tighter integration with predictive analytics models for early identification of feeding impairment—further advancing the standard of care for our most vulnerable patients.
Ultimately, Demari’s value lies not in replacing clinical judgment—but in sharpening it. By translating subtle physiologic signals into actionable data points, it enables nurses to intervene earlier, adapt more precisely, and advocate more effectively for infants whose voices cannot yet be heard. That is the enduring hallmark of expert pediatric nursing: turning science into sanctuary, one feed at a time.
